What is On-Site Rx?
Founded in 2008, On-Site Rx operates as a specialized provider of on-site pharmacy solutions, specifically engineered for large-scale enterprises with workforces exceeding 1,000 employees. By integrating pharmacy design, implementation, and ongoing management directly into the corporate environment, the firm effectively bypasses traditional supply chain inefficiencies. This model not only facilitates substantial reductions in prescription drug expenditures for both employers and their staff but also serves as a critical pillar for chronic disease management and wellness initiatives. The company maintains a notable 100% customer retention rate, reflecting its efficacy in delivering high-value, customer-centric healthcare services that align with modern corporate benefit strategies.
How much funding has On-Site Rx raised?
On-Site Rx has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in On-Site Rx
PPP
Public-Private Partnership
What's next for On-Site Rx?
The infusion of capital from this late-stage financing round provides On-Site Rx with the necessary resources to accelerate its market penetration and enhance its service delivery capabilities. As the firm moves into its next phase of growth, strategic priorities will likely include the expansion of its pharmacy footprint across new corporate campuses and the integration of advanced data analytics to further optimize prescription benefit management. By leveraging its proven track record of cost containment and health outcome improvement, On-Site Rx is poised to solidify its role as an essential partner for large employers seeking to modernize their healthcare offerings in an increasingly complex regulatory and economic landscape.
See full On-Site Rx company page
